Evidence map›Paper›PMID 35548331›Full record

ArticleFrontiers in pharmacology2022

Tianxiang Zhu, Baifei Hu, Cheng Ye, Haiming Hu, Mingzhu Yin, Zhigang Zhang, Shuiqing Li, Yanju Liu, Hongtao Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Biomaterials and biosystems · 2026
    Article
  2. Article
  3. Frontiers in pharmacology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ameliorative effects and mechanism ofFrontiers in immunology · 2025
    Article
  9. Recent advances inFrontiers in pharmacology · 2025
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tianxiang ZhuCollege of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Baifei HuCollege of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Cheng YeWuhan Customs Technology Center, Wuhan, China.
Haiming HuCollege of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Mingzhu YinCollege of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Zhigang ZhangCollege of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Shuiqing LiCollege of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Yanju LiuCollege of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Hongtao LiuCollege of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Hubei University of Chinese Medicine · CNShanghai Customs College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to elucidate the mechanism of

Indexed as

Bletilla striata oligosaccharidesgut microbiotaintestinal barrierintestinal metabolitesulcerative colitis

Identifiers

PMID35548331
PMCPMC9081565
OpenAlexW4224325337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.